In general, the pooled odds ratio of methylation was 3.45 (95% CI: 2.63–4.54) in tumor tissue versus autologous samples under random-effect method, indicating the P16INK4A promoter methylation plays an important role in the tumorigenesis of NSCLC. Here, CDKN2A is linked to neoplasm.